Being diagnosed with IgA nephropathy—also known as Berger’s disease—can raise immediate concerns about long-term health, kidney function, and financial protection for your family. One of the most common questions that follows is whether life insurance is still available, affordable, or even possible.

The good news is that many individuals with IgA nephropathy can still qualify for life insurance. Approval and pricing depend on how advanced the condition is, how well it is managed, and whether kidney function has remained stable over time. With the right underwriting approach and carrier selection, meaningful coverage is often achievable.

At Diversified Insurance Brokers, clients with kidney conditions are evaluated using a case-by-case underwriting strategy. Instead of relying on a single insurer’s opinion, applications are matched with carriers known to be more flexible toward renal impairments and chronic kidney disease.

For a broader overview of medically underwritten policies, see our guide on life insurance with pre-existing conditions .

What Is IgA Nephropathy?

IgA nephropathy is an autoimmune kidney disorder in which immunoglobulin A (IgA) deposits build up in the kidneys, causing inflammation that can interfere with filtration over time. The progression of the disease varies widely. Some individuals experience mild symptoms for decades, while others may develop reduced kidney function or chronic kidney disease (CKD).

From a life insurance underwriting standpoint, IgA nephropathy is evaluated based on measurable kidney health rather than diagnosis alone. Many applicants with early-stage disease or stable lab results remain insurable at reasonable rates.

How Life Insurance Underwriters Evaluate IgA Nephropathy

Insurance carriers focus less on the name of the condition and more on objective medical indicators. When reviewing an application involving IgA nephropathy, underwriters typically assess:

Kidney function metrics such as creatinine levels, estimated glomerular filtration rate (eGFR), and the presence or absence of proteinuria are critical. Stable lab trends over multiple years significantly improve underwriting outcomes.

Blood pressure control also plays a major role. Applicants whose hypertension is well managed—often with ACE inhibitors or ARBs—are viewed more favorably than those with uncontrolled readings.

Carriers also evaluate whether the condition has progressed to later-stage CKD, required hospitalization, or led to dialysis discussions. Earlier stages of disease generally qualify for far better rate classes.

Additional context on how kidney conditions affect underwriting can be found in our resource on life insurance for chronic illnesses .

Life Insurance Options for IgA Nephropathy

Many applicants with IgA nephropathy are eligible for fully underwritten term life insurance, particularly when kidney function remains stable and no secondary complications are present. While preferred rates are less common, standard or table-rated policies are frequently approved.

In cases where kidney impairment is more advanced, certain carriers may still offer coverage with modified terms. When traditional underwriting is not an option, guaranteed issue or simplified issue policies can provide baseline protection, though with lower face amounts.

Applicants who are younger, non-smokers, and otherwise healthy often see significantly better outcomes. This is why timing matters—applying before kidney function declines further can make a meaningful difference in cost and availability.

For applicants with concerns about lab testing or medical exams, review our explanation of what to expect during a life insurance exam .

Why a Kidney-Specific Underwriting Review Matters

Life insurance carriers vary widely in how they assess kidney disease. Some automatically decline IgA nephropathy, while others take a far more nuanced approach based on trends and physician notes.

Submitting an application without pre-screening can result in unnecessary declines that follow you across carriers. A targeted kidney questionnaire allows underwriters to review the full picture before any formal application is submitted.

This approach helps avoid wasted time, protects insurability, and ensures the case is presented to the most appropriate insurers from the start.

Why Diversified Insurance Brokers Is Different

Diversified Insurance Brokers is a family-owned, independent insurance agency that has helped clients with complex medical histories secure coverage since 1980. With access to dozens of highly rated carriers nationwide, cases involving kidney disease are matched with insurers known for more flexible underwriting.

Each case is reviewed individually, with a focus on protecting insurability, minimizing declines, and identifying the strongest possible offers based on current health—not assumptions.

Additional insights can be found on our main life insurance services page .